Major depression during interferon-α treatment: vulnerability and prevention

Figures & data

Table I. Comparison of Major Depressive Disorder (MDD) and interferon-a depressive disorder (IFN-MDD) during interferon-a treatment.

Table II. Studies examining prevention of IFN-MDD using antidepressants. Three randomized placebo-controlled trials (RCT), and four open-label studies examining the prevention of major depressive disorder (MDD), diagnosed using criteria from the Diagnostic and Statistical Manual of Mental Disorders-IV (DMS-IV), the Hamilton Depression rating scale (HAM-D), or the Montgomery-Asberg Depression Rating Scale (MADRS).

TraskPC.EsperP.RibaM.RedmanB.Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J Clin Oncol2000182316232610829053

 PubMed Web of Science ®Google Scholar

HosodaS.TakimuraH.ShibayamaM.KanamuraH.IkedaK.KumadaH.Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis. Psychiatry Clin Neurosci20005456557211043807

 PubMed Web of Science ®Google Scholar

MalaguarneraM.LaurinoA.Di FazioI.et al.Neuropsychiatrie effects and type of IFN-a in chronic hepatitis C. J Interferon Cytokine Res20012127327811429157

 PubMed Web of Science ®Google Scholar

BonaccorsoS.MarinoV.BiondiM.GrimaldiF.IppolitiF.MaesM.Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Dis20027223724112450640

 PubMed Web of Science ®Google Scholar

RenaultPF.HoofnagleJH.ParkY.et al.Psychiatric complications of long-term interferon alfa therapy. Arch IntMed198714715771580

 Google Scholar

Spath-SchwalbeE.LangeT.PerrasB.FehmHL.BornJ.Interferon-alpha acutely impairs sleep in healthy humans. Cytokine20001251852110857770

 PubMed Web of Science ®Google Scholar

CapuronL.HauserP.Hinze-SelchD.MillerAH.NeveuPJ.Treatment of cytokine-induced depression. Brain Behav Immunology200216575580

 PubMed Web of Science ®Google Scholar

PoutiainenE.HokkanenL.NiemiM.FarkkilaM.Reversible cognitive decline during high-dose [alpha]-interferon treatment. Pharmacol Biochem Behav1994479019058029260

 PubMed Web of Science ®Google Scholar

DusheikoG.Side effects of alpha interferon in chronic hepatitis C. Hepatol199726112S121S

 PubMed Web of Science ®Google Scholar

FontanaRJ.SchwartzSM.GebremariamA.LokASF.MoyerCA.Emotional distress during interferon-a-2B and ribavirin treatment of chronic hepatitis C. Psychosomat200234378385

 Google Scholar

JanssenH.BrouwerJ.van der MastR.SchalmS.Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol1994212412437989716

 PubMed Web of Science ®Google Scholar

EnnsMW.CoxBJ.Personality dimensions and depression: review and commentary. Can J Psychiatry - Revue Canadienne de Psychiatrie199742274284

 PubMed Web of Science ®Google Scholar

BoyceP.MasonC.An overview of depression-prone personality traits and the role of interpersonal sensitivity. Austr New Zealand J Psychiatry19963090103

 PubMed Web of Science ®Google Scholar

JoinerTE.Depression in its interpersonal context. In: Gotlieb IH, Hammen CL, eds. Handbook of Depression. New York, NY: Guilford.2002295313

 Google Scholar

FabregaHJ.Disease and Social Behavior: an Interdisciplinary Perspective. Cambridge, MA: MIT Press.1974

 Google Scholar

MullenL.S.BlancoC.VaughanSC.VaughanR.RooseSP.Defense mechanisms and personality in depression. Depress Anx199910168174

 PubMed Web of Science ®Google Scholar

GilbertP.Evolutionary approaches to psychopathology: the role of natural defences. Aust N Z J Psychiatry200135172711270452

 PubMed Web of Science ®Google Scholar

KihlstromJF.Cantor KihlstromL.Somatization as illness behavior. Adv Mind-Body Med20011724024311931045

 PubMedGoogle Scholar

MusselmanDL.LawsonDH.GumnickJF.et al.Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med200134496196611274622

 PubMed Web of Science ®Google Scholar

PaceTW.MletzkoTC.AlagbeO.et al.Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry20061631630163316946190

 PubMed Web of Science ®Google Scholar

RaisonCL.WoolwineBJ.DemetrashviliZM.et al.Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Alimentary Pharmacol Therapeut20072511631174

 PubMed Web of Science ®Google Scholar

GleasonOC.FucciJC.YatesWR.PhilipsenMA.Preventing relapse of major depression during interferon-a therapy for hepatitis C - a pilot study. Dig Dis Sci2007522557256317436092

 PubMed Web of Science ®Google Scholar

KrausMR.ShaferA.Al-TaieO.ScheurlenM.Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepatitis20061296100

 Web of Science ®Google Scholar

SchaeferM.SchwaigerM.GarkishAS.et al.Prevention of interferonalpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol20054279379815885349

 PubMed Web of Science ®Google Scholar